Utah Financial Statements From 2010 to 2026

UTMD Stock  USD 64.10  0.37  0.58%   
Utah Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Utah Medical's valuation are provided below:
Gross Profit
22 M
Profit Margin
0.293
Market Capitalization
205.4 M
Enterprise Value Revenue
3.0494
Revenue
38.5 M
There are over one hundred nineteen available fundamental trend indicators for Utah Medical Products, which can be analyzed over time and compared to other ratios. Investors should ensure to double-check all of Utah Medical's current performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 289.5 M. The current year's Enterprise Value is expected to grow to about 202 M

Utah Medical Total Revenue

36.96 Million

Check Utah Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Utah Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 675.3 K or Total Revenue of 37 M, as well as many indicators such as Price To Sales Ratio of 3.48, Dividend Yield of 0.0242 or PTB Ratio of 1.48. Utah financial statements analysis is a perfect complement when working with Utah Medical Valuation or Volatility modules.
  
Build AI portfolio with Utah Stock
Check out the analysis of Utah Medical Correlation against competitors.

Utah Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets62.8 M122.5 M92.6 M
Slightly volatile
Short and Long Term Debt Total289 K304.2 K3.3 M
Slightly volatile
Other Current Liabilities2.5 M1.7 MM
Slightly volatile
Total Current Liabilities4.5 M2.6 M5.1 M
Slightly volatile
Total Stockholder Equity125.2 M119.3 M84.9 M
Slightly volatile
Property Plant And Equipment Net9.6 M9.9 M9.3 M
Slightly volatile
Cash90 M85.8 M45.5 M
Slightly volatile
Non Current Assets Total27.1 M24.8 M40.4 M
Slightly volatile
Cash And Short Term Investments90 M85.8 M45.5 M
Slightly volatile
Net Receivables4.4 M3.5 MM
Slightly volatile
Common Stock Shares Outstanding4.9 M3.2 M4.1 M
Slightly volatile
Liabilities And Stockholders Equity62.8 M122.5 M92.6 M
Slightly volatile
Non Current Liabilities Total642.2 K676 K6.6 M
Slightly volatile
Inventory4.8 M7.9 M5.8 M
Slightly volatile
Other Current Assets502.6 K529 K613.6 K
Slightly volatile
Total Liabilities3.1 M3.3 M11.6 M
Slightly volatile
Property Plant And Equipment Gross40.7 M38.7 M18.4 M
Slightly volatile
Total Current Assets102.6 M97.7 M56.2 M
Slightly volatile
Intangible Assets3.1 M3.3 M18.7 M
Slightly volatile
Accounts Payable710.7 K911 K870 K
Pretty Stable
Short Term Debt47.9 K50.4 K1.2 M
Slightly volatile
Common Stock Total Equity32 K32.4 K37.8 K
Slightly volatile
Common Stock31.7 K29.7 K37.4 K
Slightly volatile
Property Plant Equipment10.1 M11.8 M9.9 M
Slightly volatile
Good Will13.3 M14.9 M13.9 M
Pretty Stable
Other Liabilities4.9 M3.8 M4.2 M
Pretty Stable
Retained Earnings Total Equity93.3 M144.9 M91.2 M
Slightly volatile
Long Term Debt Total8.1 M4.6 M6.8 M
Slightly volatile
Capital Surpluse214.6 K225.9 K945 K
Slightly volatile
Non Current Liabilities Other3.5 M3.6 M3.6 M
Slightly volatile
Short and Long Term Debt3.1 M3.5 M3.8 M
Slightly volatile
Net Invested Capital115.2 M135 M96.2 M
Slightly volatile
Net Working Capital76.6 M106.5 M61.6 M
Slightly volatile
Capital Stock28.8 K29.7 K35.7 K
Slightly volatile
Capital Lease Obligations261.3 K253.8 K344.7 K
Slightly volatile

Utah Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.5 MMM
Slightly volatile
Total Revenue37 M38.5 M40.5 M
Slightly volatile
Gross Profit20.8 M19.9 M24.3 M
Slightly volatile
Other Operating Expenses24.5 M27.1 M25.7 M
Slightly volatile
Operating Income12.6 M11.4 M14.9 M
Slightly volatile
EBIT12.7 M14.1 M15.1 M
Slightly volatile
EBITDA15.3 M17.1 M19.1 M
Slightly volatile
Cost Of Revenue16.1 M18.6 M16.2 M
Slightly volatile
Total Operating Expenses8.4 M8.5 M9.5 M
Slightly volatile
Income Before Tax13.2 M14.1 M15.5 M
Slightly volatile
Net Income9.9 M11.3 M11.8 M
Slightly volatile
Income Tax Expense3.8 M2.8 M3.7 M
Very volatile
Research Development480.2 K668 K584.7 K
Pretty Stable
Selling General Administrative6.7 M4.2 M7.1 M
Pretty Stable
Net Income Applicable To Common Shares11.8 M18.9 M14.1 M
Slightly volatile
Selling And Marketing Expenses1.5 M1.7 M1.9 M
Slightly volatile
Net Income From Continuing Ops16.7 M16 M15.3 M
Pretty Stable
Tax Provision3.3 M2.6 M3.8 M
Pretty Stable
Interest Income306.7 K292.1 K162.4 K
Slightly volatile
Reconciled Depreciation6.1 M3.3 M4.3 M
Slightly volatile

Utah Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation309.1 K294.4 K167.4 K
Slightly volatile
Begin Period Cash Flow112.1 M106.8 M43.3 M
Slightly volatile
Depreciation2.6 M3.3 MM
Slightly volatile
Capital Expenditures256.7 K270.2 KM
Very volatile
Total Cash From Operating Activities12.8 M17.1 M15.6 M
Slightly volatile
Net Income10.3 M16 M12.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.484.80865.5831
Slightly volatile
Dividend Yield0.02420.02190.0177
Very volatile
PTB Ratio1.481.5532.9053
Slightly volatile
Days Sales Outstanding49.533.373138.446
Slightly volatile
Book Value Per Share37.8336.032623.4769
Slightly volatile
Operating Cash Flow Per Share2.143.814.0661
Slightly volatile
Stock Based Compensation To Revenue0.00590.00560.0033
Slightly volatile
Capex To Depreciation0.09020.0950.6929
Slightly volatile
PB Ratio1.481.5532.9053
Slightly volatile
EV To Sales3.22.58234.7253
Pretty Stable
ROIC0.07220.0760.1224
Slightly volatile
Inventory Turnover2.232.34972.9325
Slightly volatile
Net Income Per Share3.583.40973.2654
Slightly volatile
Days Of Inventory On Hand87.36155127
Slightly volatile
Payables Turnover16.0120.466519.2978
Slightly volatile
Sales General And Administrative To Revenue0.120.08070.1552
Very volatile
Research And Ddevelopement To Revenue0.01880.01730.0144
Pretty Stable
Capex To Revenue0.00630.00660.0443
Very volatile
Cash Per Share27.225.908212.723
Slightly volatile
POCF Ratio16.6716.716.0996
Slightly volatile
Interest Coverage291277186
Slightly volatile
Payout Ratio0.420.35930.3382
Pretty Stable
Capex To Operating Cash Flow0.01730.01820.1219
Very volatile
Days Payables Outstanding23.117.83419.9755
Slightly volatile
Income Quality1.020.961.3141
Slightly volatile
ROE0.08990.09460.1447
Slightly volatile
EV To Operating Cash Flow15.8510.2913.915
Pretty Stable
PE Ratio14.1616.412220.5142
Very volatile
Return On Tangible Assets0.09960.10480.2074
Slightly volatile
Earnings Yield0.07230.06090.0526
Very volatile
Intangibles To Total Assets0.180.12150.3405
Slightly volatile
Current Ratio39.537.62214.5607
Slightly volatile
Receivables Turnover6.8610.9379.9616
Slightly volatile
Graham Number55.2152.576941.1955
Slightly volatile
Shareholders Equity Per Share37.8336.032623.4769
Slightly volatile
Debt To Equity0.00310.00330.0824
Slightly volatile
Capex Per Share0.05740.06040.5187
Very volatile
Revenue Per Share12.2211.637511.1104
Slightly volatile
Interest Debt Per Share0.08250.08680.8826
Slightly volatile
Debt To Assets0.0030.00320.0519
Slightly volatile
Enterprise Value Over EBITDA11.25.8310.3772
Very volatile
Short Term Coverage Ratios250238186
Slightly volatile
Price Earnings Ratio14.1616.412220.5142
Very volatile
Operating Cycle123189165
Slightly volatile
Price Book Value Ratio1.481.5532.9053
Slightly volatile
Days Of Payables Outstanding23.117.83419.9755
Slightly volatile
Dividend Payout Ratio0.420.35930.3382
Pretty Stable
Price To Operating Cash Flows Ratio16.6716.716.0996
Slightly volatile
Pretax Profit Margin0.270.36630.3614
Slightly volatile
Ebt Per Ebit1.171.23751.051
Slightly volatile
Operating Profit Margin0.260.2960.3483
Very volatile
Effective Tax Rate0.340.20010.2566
Slightly volatile
Company Equity Multiplier1.41.02751.2337
Slightly volatile
Long Term Debt To Capitalization0.01620.01710.0569
Slightly volatile
Total Debt To Capitalization0.00310.00330.0617
Slightly volatile
Return On Capital Employed0.09030.09510.167
Slightly volatile
Debt Equity Ratio0.00310.00330.0824
Slightly volatile
Ebit Per Revenue0.260.2960.3483
Very volatile
Quick Ratio36.334.567712.9773
Slightly volatile
Dividend Paid And Capex Coverage Ratio5.693.793.7319
Very volatile
Net Income Per E B T0.580.79990.7387
Slightly volatile
Cash Ratio34.6633.008511.9713
Slightly volatile
Cash Conversion Cycle107171147
Slightly volatile
Operating Cash Flow Sales Ratio0.260.330.3612
Slightly volatile
Days Of Inventory Outstanding87.36155127
Slightly volatile
Days Of Sales Outstanding49.533.373138.446
Slightly volatile
Cash Flow Coverage Ratios41.4739.4936.1352
Slightly volatile
Price To Book Ratio1.481.5532.9053
Slightly volatile
Fixed Asset Turnover4.413.88784.3665
Very volatile
Capital Expenditure Coverage Ratio59.6456.833.6124
Slightly volatile
Price Cash Flow Ratio16.6716.716.0996
Slightly volatile
Enterprise Value Multiple11.25.8310.3772
Very volatile
Debt Ratio0.0030.00320.0519
Slightly volatile
Cash Flow To Debt Ratio41.4739.4936.1352
Slightly volatile
Price Sales Ratio3.484.80865.5831
Slightly volatile
Return On Assets0.08750.09210.1211
Very volatile
Asset Turnover0.30.31430.4674
Slightly volatile
Net Profit Margin0.210.2930.2742
Slightly volatile
Gross Profit Margin0.440.5160.5804
Very volatile
Price Fair Value1.481.5532.9053
Slightly volatile
Return On Equity0.08990.09460.1447
Slightly volatile

Utah Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap289.5 M275.7 M251.3 M
Slightly volatile
Enterprise Value202 M192.4 M190 M
Slightly volatile

Utah Fundamental Market Drivers

Utah Upcoming Events

23rd of April 2024
Upcoming Quarterly Report
View
31st of March 2024
Next Fiscal Quarter End
View

About Utah Medical Financial Statements

Utah Medical stakeholders use historical fundamental indicators, such as Utah Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Utah Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Utah Medical's assets and liabilities are reflected in the revenues and expenses on Utah Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Utah Medical Products. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue294.3 K232.6 K
Total Revenue38.5 M37 M
Cost Of Revenue18.6 M16.1 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.08  0.12 
Research And Ddevelopement To Revenue 0.02  0.02 
Capex To Revenue 0.01  0.01 
Revenue Per Share 11.64  12.22 
Ebit Per Revenue 0.30  0.26 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:
Check out the analysis of Utah Medical Correlation against competitors.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.06)
Dividend Share
1.225
Earnings Share
3.51
Revenue Per Share
11.889
Quarterly Revenue Growth
(0.01)
Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.